These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37038955)

  • 1. Immunological interactions in helminths-SARS CoV-2 coinfection: Could old enemy be a friend today?
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Elhadad H; Alexiou A; Papadakis M; Ogaly HA; Elgazzar AM; Batiha GE
    Parasite Immunol; 2023 May; 45(5):e12982. PubMed ID: 37038955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 and helminth co-infections, and environmental pollution exposure: An epidemiological and immunological perspective.
    Naidoo P; Ghazi T; Chuturgoon AA; Naidoo RN; Ramsuran V; Mpaka-Mbatha MN; Bhengu KN; Nembe N; Duma Z; Pillay R; Singh R; Mkhize-Kwitshana ZL
    Environ Int; 2021 Nov; 156():106695. PubMed ID: 34171587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Old friends meet a new foe: A potential role for immune-priming parasites in mitigating COVID-19 morbidity and mortality.
    Cepon-Robins TJ; Gildner TE
    Evol Med Public Health; 2020; 2020(1):234-248. PubMed ID: 33235797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation of COVID-19 severity by helminth co-infection: Implications for COVID-19 vaccine efficacy.
    Akelew Y; Andualem H; Ebrahim E; Atnaf A; Hailemichael W
    Immun Inflamm Dis; 2022 Mar; 10(3):e573. PubMed ID: 34861106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
    Aboudounya MM; Heads RJ
    Mediators Inflamm; 2021; 2021():8874339. PubMed ID: 33505220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
    Root-Bernstein R
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fight Against Severe COVID-19: Can Parasitic Worms Contribute?
    Cai P; Mu Y; McManus DP
    Front Immunol; 2022; 13():849465. PubMed ID: 35222441
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Lethality in Sub-Saharan Africa and Helminth Immune Modulation.
    Fonte L; Acosta A; Sarmiento ME; Ginori M; García G; Norazmi MN
    Front Immunol; 2020; 11():574910. PubMed ID: 33117371
    [No Abstract]   [Full Text] [Related]  

  • 10. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helminth antigens differentially modulate the activation of CD4
    Adjobimey T; Meyer J; Terkeš V; Parcina M; Hoerauf A
    BMC Med; 2022 Jun; 20(1):241. PubMed ID: 35764965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State.
    Domovitz T; Ayoub S; Werbner M; Alter J; Izhaki Tavor L; Yahalom-Ronen Y; Tikhonov E; Meirson T; Maman Y; Paran N; Israely T; Dessau M; Gal-Tanamy M
    Microbiol Spectr; 2022 Dec; 10(6):e0115022. PubMed ID: 36314945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helminth coinfection and COVID-19: An alternate hypothesis.
    Hays R; Pierce D; Giacomin P; Loukas A; Bourke P; McDermott R
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008628. PubMed ID: 32804930
    [No Abstract]   [Full Text] [Related]  

  • 14. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.
    Xiang J; Lu M; Shi M; Cheng X; Kwakwa KA; Davis JL; Su X; Bakewell SJ; Zhang Y; Fontana F; Xu Y; Veis DJ; DiPersio JF; Ratner L; Sanderson RD; Noseda A; Mollah S; Li J; Weilbaecher KN
    J Virol; 2022 Apr; 96(7):e0005722. PubMed ID: 35319225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients.
    Sawalha AH; Zhao M; Coit P; Lu Q
    Clin Immunol; 2020 Jun; 215():108410. PubMed ID: 32276140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging issues in COVID-19 vaccination in tropical areas: Impact of the immune response against helminths in endemic areas.
    Chacin-Bonilla L; Chacón-Fonseca N; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2021; 42():102087. PubMed ID: 34051352
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
    Gemmati D; Bramanti B; Serino ML; Secchiero P; Zauli G; Tisato V
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.